GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

N/ACompletedNCT01988545

Zealand University Hospital8 enrolled

Overview

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters, in healthy subjects, 4 arms, task force monitor

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

DOUBLE

Enrollment

Conditions

Healthy

Interventions

1,5 nmol/kg,GLP-1 sc injectionOTHER

1,5 nmol/kg GLP-1 9-36amide, sc injectionOTHER

Exendin-4 ;10 ug,sc injectionOTHER

saline

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * healthy subjects Exclusion Criteria: * medical conditions

Locations (1)

Køge Hospital

Køge, State..., Denmark

Outcomes

Primary Outcomes

blood flow

blood flow change measured by ultra sound

Time frame: with in 120 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.